SCHEMBL3462993

SCHEMBL3462993

[C]#CCCCC#C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15941914 0.93
SCHEMBL4503067 0.90
SCHEMBL8769955 0.82
SCHEMBL973460 0.82
SCHEMBL223825 0.79
Bromide SCHEMBL28242864 0.78
SCHEMBL10179319 0.75 TSHR (0.36)
SCHEMBL8769971 0.73
SCHEMBL1062616 0.73
SCHEMBL2520528 0.70 MAPT (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101590-A1 METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES THE SCRIPPS RESEARCH INSTITUTE 2024-03-28 US disclosed
US-11634451-B2 Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides THE SCRIPPS RESEARCH INSTITUTE (US) 2023-04-25 US disclosed
US-11608323-B2 Herbicidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2023-03-21 US disclosed
EP-3054773-B1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2022-01-26 EP disclosed
EP-3656781-A1 A METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES The Scripps Research Institute (US) 2020-05-27 EP disclosed
US-10653143-B2 Herbicidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2020-05-19 US disclosed
US-10626138-B2 Method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides THE SCRIPPS RESEARCH INSTITUTE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT OF HEALTH AND HUMAN SERVICES (DHHS) (US) 2020-04-21 US disclosed
US-20200040027-A1 A METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES THE SCRIPPS RESEARCH INSTITUTE 2020-02-06 US disclosed
US-10499640-B2 Herbicidal compounds SYNGENTA PARTICIPATIONS AG (CH) 2019-12-10 US disclosed
EP-3154965-B1 HERBICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2019-05-08 EP disclosed
US-20020034774-A1 Treatment or prophylaxis of diseases caused by pilus-forming bacteria HULTGREN SCOTT (US) 2002-03-21 US disclosed
US-6153396-A DRUG SCREENING BY ADDING COMPOUND TO MIXTURE OF CHAPERONE AND PILUS SUBUNIT AND DETERMINING THE CHANGE IN BINDING; BACTERICIDES FOR URINARY TRACT INFECTIONS SIGA PHARMACEUTICALS, INC. (US) 2000-11-28 US disclosed
US-6001823-A NOVEL PYRANOSIDES WHICH ARE BELIEVED TO BE CAPABLE OF INTERACTING WITH PERIPLASMIC MOLECULAR CHAPERONES WASHINGTON UNIVERSITY 1999-12-14 US disclosed
EP-0730601-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTIONS WASHINGTON UNIVERSITY (US) 1996-09-11 EP disclosed
EP-0725563-A1 MARINE STRUCTURE J.C. HEMPEL'S SKIBSFARVE-FABRIK A/S (DK) 1996-08-14 EP disclosed
WO-1995014028-A9 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTIONS 1995-08-10 WO disclosed
WO-1995014028-A2 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTIONS WASHINGTON UNIVERSITY (US) 1995-05-26 WO disclosed
WO-1995011592-A1 MARINE STRUCTURE J.C. HEMPEL'S SKIBSFARVE-FABRIK A/S (DK) 1995-05-04 WO disclosed
EP-0178139-B1 PROCESS FOR PRODUCING 2,3-DISUBSTITUTED -4-SUBSTITUTED CYCLOPENTANONES, ENANTIOMORPHS, OR MIXTURES THEREOF TEIJIN LIMITED (JP) 1989-07-05 EP disclosed
US-4297492-A STABILIZERS FOR PLASTICS CIBA-GEIGY CORPORATION (US) 1981-10-27 US disclosed